Diagnostic Efficacy of Serum Asialo α1-Acid Glycoprotein Levels for Advanced Liver Fibrosis and Cirrhosis in Patients with Chronic Hepatitis B Compared to That in Healthy Subjects: A Prospective Study

Background: Serum asialo α1-acid gycoprotein (AsAGP) is a novel biomarker specific to liver fibrosis. Aim: To evaluate the diagnostic efficacy of serum AsAGP levels in classifying the severity of liver fibrosis and differentiating liver cirrhosis (LC) in patients with chronic hepatitis B (CHB) from...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yoonseok, Bae, Seryun, Kim, Ji Hoon, Kwak, Minjung, Jeon, So Yeon, Kim, Taehyung, Yim, Sun Young, Lee, Young-Sun, Jung, Young Kul, Seo, Yeon Seok, Yim, Hyung Joon, Yeon, Jong Eun, Byun, Kwan Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863335/
https://www.ncbi.nlm.nih.gov/pubmed/36675640
http://dx.doi.org/10.3390/jcm12020712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863335/
https://www.ncbi.nlm.nih.gov/pubmed/36675640
http://dx.doi.org/10.3390/jcm12020712

Ejemplares similares